Improvement of Care & Outcome
The number of people with type 1 diabetes (PWDs) is still increasing. As type 1 diabetes can not yet be prevented or cured, optimal treatment and prevention of (long-term) complications are necessary. New technology has come a long way in improving both glycemic outcomes and quality of life of people with T1D. Increasing numbers of PWDs combined with increasing costs for new technology pose an increasing burden on healthcare resources, with costs expecting to rise even more due to increasing use of newer and more sophisticated technologies. Not many studies have investigated healthcare use and costs in pediatric care on a national level. This study, co-authored by Diabeter pediatric endocrinologists Dick Mul and Theo Sas, aimed to asses healthcare resource utilization, hospital costs and its determinants in Dutch children and adolescents (0-18 years) with diabetes.
In this retrospective, observational, nationwide cohort study, Dutch healthcare reimbursement data of 5,474 children with diabetes were used. In the Netherlands a national diagnosis coding system, the Diagnosis Treatment Combinations (DBC) system is used. No distinction can be made between type 1 and type 2 diabetes as no codes are specified for this. A dataset with benchmark information on claimed care products (i.e. DBCs) between 1 January 2019 and 31 December 2019 from affiliated hospitals was provided by LOGEX Healthcare Analytics.
Concluding, the authors state